Reverse Peptide operates as a vendor offering both retail and bulk sales for its catalogue of 26 peptides. The business maintains a minimum order quantity of one vial per purchase. Currently, there is no available data regarding the vendor's headquarters, shipping logistics, or third-party testing practices. Because there is no community feedback or anecdotal evidence to draw from, the vendor remains an unverified entity with limited public information regarding its operational history or quality control standards.
Data last updated
Anecdotal signals
Testing coverage
This vendor’s site blocks automated verification, so we have not been able to read any certificates. Testing scores zero: we are not willing to imply a vendor is tested when we have not been able to look.
Price
regional price-per-mg comparisons
We don't issue verdicts — we publish the evidence and let it speak. Our automated site audit has verified the vendor's published catalogue and COA surface. So far we have captured no substantiated community reports and no lab documents for Reverse Peptide. That absence is itself information: it does not prove anything is wrong, but it means independent evidence is thin — proceed accordingly.
24 catalogue peptides known; no COAs captured yet.